miDiagnostics

Series-B
midiagnostics.com Biotech & Healthcare Heverlee, Belgium
Total Funding $34.9M
Latest Round $34.9M Series-B
Last Announced Dec 4, 2024
Investors 7 Backers
Decision Makers 6 Available

About miDiagnostics

miDiagnostics is developing a comprehensive menu of syndromic tests for screening, diagnosis and monitoring of a wide range of health conditions.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Heverlee, Belgium
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website midiagnostics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $34,880,000 · Series-B

    Backed by Thermo Fisher Scientific

Investors & Backers

7
Thermo Fisher Scientific
Lead
Alychlo
European Investment Bank Group
Pamica AB
Rudi Pauwels
Urbain Vandeurzen
VMF Invest

Funding History

1 Round
Series-B equity · Dec 4, 2024

Round backers: Thermo Fisher Scientific

Founders & Leadership

3

David Morrow

Senior VP Engineering & Product Development

Work email & phone locked Unlock →

Katleen Verleysen

Chief Executive Officer

Work email & phone locked Unlock →

Nicolas Vergauwe

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts